Effects of atorvastatin on postprandial plasma lipoproteins in postinfarction patients with combined hyperlipidaemia

被引:23
作者
Boquist, S [1 ]
Karpe, F
Danell-Toverud, K
Hamsten, A
机构
[1] Karolinska Inst, Karolinska Hosp, King Gustaf V Res Inst, Atherosclerosis Res Unit, S-17176 Stockholm, Sweden
[2] Karolinska Inst, Karolinska Hosp, Dept Cardiol, S-10401 Stockholm, Sweden
关键词
atorvastatin; alimentary lipaemia; triglcerides; very loan density lipoproteins; chylomicron remnants;
D O I
10.1016/S0021-9150(01)00689-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Enhanced and prolonged postprandial lipaernia is implicated in coronary and carotid artery disease. This study assessed the effects of atorvastatin, a 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor, on postprandial plasma concentrations of triglyceride-rich lipoproteins (TRLs). Sixteen middle-aged men with combined hyperlipidaemia (baseline low density lipoprotein (LDL) cholesterol and plasma triglyceride concentrations (median (interquartile range) of 4.54 (4.17 - 5.26)) and 2.66 (2.04 - 3.20) mol/l, respectively) and previous myocardial infarction randomised to atorvastatin 40 mg or placebo once daily for 8 weeks in a double-blind, cross-over design. The apolipoprotein (apo) B-48 and B-100 contents,were determined in subfractions of TRLS as a measure of chylomicron remnant and very low density lipoprotein (VLDL) particle concentrations (expressed Lis mg apo B-48 or apo B-100 per litre of plasma). in the fasting state and after intake of a mixed meal. Atorvastatin treatment reduced significantly the fasting plasma concentrations of VLDL cholesterol, LDL cholesterol and VLDL triglycerides (median% change) by 29. 44 and 27%, respectively, and increased high density lipoprotein (HDL) cholesterol by 19%, compared with baseline. The postprandial plasma concentrations of large (Svedberg flotation rate (Sf) 60-400) and small (Sf 20-60) VLDLs and chylomicron remnants were almost halved compared with baseline (mean 0-6 h plasma concentrations were reduced by 48% for Sf 60-400 apo B-100, by 46% for Sf 60-400 apo B-48. b 46%) for Sf 20-60 apo B-100 and by 27% for SF20-60 apo B-48). and the postprandial triglyceridaemia was reduced by 23% during active treatment. In conclusion, atorvastatin 40 mg once daily causes profound reductions of postprandial plasma concentrations of all TRLs in combined hyperlipidaemic patients with premature coronary artery disease. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:163 / 170
页数:8
相关论文
共 41 条
  • [1] Effect of a new HMG-CoA reductase inhibitor, atorvastatin, on lipids, apolipoproteins and lipoprotein particles in patients with elevated serum cholesterol and triglyceride levels
    Alaupovic, P
    Heinonen, T
    Shurzinske, L
    Black, DM
    [J]. ATHEROSCLEROSIS, 1997, 133 (01) : 123 - 133
  • [2] ANDERSSON C, 1999, ARTERIOSCLER THROMB, V19, P2422
  • [3] Post-prandial metabolism of triglyceride-rich lipoproteins in non-insulin-dependent diabetic patients before and after bezafibrate treatment
    Attia, N
    Durlach, V
    Roche, D
    Paul, JL
    Soni, T
    Zahouani, A
    Landron, F
    Labrousse, F
    Leutenegger, M
    GirardGloba, A
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1997, 27 (01) : 55 - 63
  • [4] Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia
    BakkerArkema, RG
    Davidson, MH
    Goldstein, RJ
    Davignon, J
    Isaacsohn, JL
    Weiss, SR
    Keilson, LM
    Brown, WV
    Miller, VT
    Shurzinske, LJ
    Black, DM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (02): : 128 - 133
  • [5] EFFECT OF TREATMENT WITH A HYDROXYMETHYLGLUTARYL COENZYME-A REDUCTASE INHIBITOR ON FASTING AND POSTPRANDIAL PLASMA-LIPOPROTEINS AND CHOLESTERYL ESTER TRANSFER ACTIVITY IN PATIENTS WITH NIDDM
    BHATNAGAR, D
    DURRINGTON, PN
    KUMAR, S
    MACKNESS, MI
    DEAN, J
    BOULTON, JM
    [J]. DIABETES, 1995, 44 (04) : 460 - 465
  • [6] Bjorkegren J, 1996, J LIPID RES, V37, P76
  • [7] Accumulation of apolipoprotein C-I-rich and cholesterol-rich VLDL remnants during exaggerated postprandial triglyceridemia in normolipidemic patients with coronary artery disease
    Björkegren, J
    Boquist, S
    Samnegård, A
    Lundman, P
    Tornvall, P
    Ericsson, CG
    Hamsten, A
    [J]. CIRCULATION, 2000, 101 (03) : 227 - 230
  • [8] Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common carotid intima-media thickness in healthy, middle-aged men
    Boquist, S
    Ruotolo, G
    Tang, R
    Björkegren, J
    Bond, MG
    de Faire, U
    Karpe, F
    Hamsten, A
    [J]. CIRCULATION, 1999, 100 (07) : 723 - 728
  • [9] Effects of a cardioselective β-blocker on postprandial triglyceride-rich lipoproteins, low density lipoprotein particle size and glucose-insulin homeostasis in middle-aged men with modestly increased cardiovascular risk
    Boquist, S
    Ruotolo, G
    Hellénius, ML
    Danell-Toverud, K
    Karpe, F
    Hamsten, A
    [J]. ATHEROSCLEROSIS, 1998, 137 (02) : 391 - 400
  • [10] Lowering effects of four different statins on serum triglyceride level
    Branchi, A
    Fiorenza, AM
    Rovellini, A
    Torri, A
    Muzio, F
    Macor, S
    Sommariva, D
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 55 (07) : 499 - 502